| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-14-2089 |
| P698 | PubMed publication ID | 25762540 |
| P50 | author | Louis Boon | Q89457618 |
| Gabriela Bomfim Ferreira | Q113940295 | ||
| Magdalena Winiarska | Q114330806 | ||
| Jakub Gołąb | Q16561026 | ||
| Patrizia Agostinis | Q30111808 | ||
| Abhishek D. Garg | Q38322540 | ||
| Chantal Mathieu | Q54656098 | ||
| Angelika Muchowicz | Q59676884 | ||
| P2093 | author name string | Marie-Lise Gougeon | |
| Joost van den Oord | |||
| Nicole Prada | |||
| Shaun Martin | |||
| Marguerite Stas | |||
| Santeri Kiviluoto | |||
| Jasper Wouters | |||
| Aleksandra M Dudek-Perić | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1603-1614 | |
| P577 | publication date | 2015-03-11 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin | |
| P478 | volume | 75 |
| Q28069018 | Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma |
| Q28072922 | Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies |
| Q55512760 | BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells. |
| Q60954585 | CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells |
| Q38766974 | Calreticulin, a therapeutic target? |
| Q47614555 | Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. |
| Q36591378 | Cell surface localization of importin α1/KPNA2 affects cancer cell proliferation by regulating FGF1 signalling |
| Q35535140 | Combinatorial strategies for the induction of immunogenic cell death |
| Q92652869 | Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma |
| Q26781215 | Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies |
| Q90629204 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death |
| Q39397491 | Cytokines in immunogenic cell death: Applications for cancer immunotherapy |
| Q38928826 | DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing. |
| Q46586294 | Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma |
| Q39585070 | Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality |
| Q64107945 | Immunogenic Cell Death and Immunotherapy of Multiple Myeloma |
| Q28386858 | Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation |
| Q39281286 | Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis |
| Q98223086 | Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors |
| Q37722551 | Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells |
| Q60047604 | Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients |
| Q40251215 | Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion |
| Q57082886 | Melanoma immunotherapy |
| Q42613506 | Melanoma targeting with the loco-regional chemotherapeutic, Melphalan: From cell death to immunotherapeutic efficacy |
| Q36301061 | Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death |
| Q36405909 | New photodynamic therapy with next-generation photosensitizers |
| Q64271992 | Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells |
| Q90608556 | Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity |
| Q58114693 | Novel therapeutic compound acridine-retrotuftsin action on biological forms of melanoma and neuroblastoma |
| Q38586919 | Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations |
| Q47118268 | Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression |
| Q60958906 | Reprogramming factors induce proliferation and inhibit apoptosis of melanoma cells by changing the expression of particular genes |
| Q36413628 | Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal |
| Q64236899 | Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma |
| Q50020799 | Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. |
| Q47135720 | Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma |
| Q55041056 | The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion. |
| Q41067821 | Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants. |
| Q56594845 | Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics |
| Q89457645 | Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology |
Search more.